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Abstract & Keywords 1 
 2 
Objectives: Evaluate whether insomnia symptoms and short or long sleep duration, alone or 3 
in combination, are robustly associated with subsequent trajectory of mental health 4 
symptoms.  5 
 6 
Methods: Participants were 2,598 individuals (15-to-94 years of age) with elevated mental 7 
health symptoms at baseline (2013-14). Associations of baseline insomnia symptoms and 8 
sleep duration with two-year trajectory of mental health were estimated and adjusted for 9 
multiple potential confounders. Outcomes included recovery (well at both follow-up 10 
timepoints), intermittent symptoms (unwell at one follow-up timepoint), and chronic 11 
symptoms (unwell at each follow-up timepoint).  12 
 13 
Results: Adjusted for age and sex, baseline insomnia symptoms predicted intermittent (OR 14 
1.43, 95% CI 1.15–1.80) and chronic (OR 2.16, 95% CI 1.77–2.68) trajectories of mental 15 
health symptoms. Short sleep duration (<6h and ≥6 to <7h) only predicted a chronic 16 
trajectory (ORs 1.70–2.06). Associations were attenuated but significant after confounder 17 
adjustment. Those who experienced both insomnia and short (<7h) sleep duration had the 18 
greatest risk of chronic mental health symptoms (OR 2.35, 95% CI 1.60–3.45).  19 
 20 
Conclusion: A focus on just sleep duration or insomnia symptoms in those with elevated 21 
mental health symptoms will not be adequate to address chronicity. Both components of sleep 22 
disturbance, and in particular their co-occurrence, should be addressed. 23 
 24 
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 3 
Main Text 1 
Insomnia symptoms and short sleep duration predict trajectory of mental health 2 
symptoms. 3 
1. Introduction 4 
There is a bi-directional link between sleep disturbance and mental health symptoms, with 5 
disordered sleep representing both a symptom of and risk factor for the development of 6 
common mental disorders.1-6  7 
Sleep disturbance is a multidimensional concept, comprised of such phenomena as insomnia 8 
symptoms, sleep duration, and sleep schedule/timing.7 Recent research has explored how 9 
these sleep disturbance dimensions combine to predict mental health incidence and 10 
prevalence,7-11 with a particular focus on the combination of insomnia symptoms and short 11 
sleep duration.  12 
One large-scale cross-sectional study (n = 3911) found that those experiencing insomnia with 13 
short sleep duration display higher risk of depression than those with insomnia but normal 14 
sleep duration, and greater prevalence of depression and anxiety than healthy-sleeping 15 
controls.8 In another large-scale study (n = 1137), Fernandez-Mendoza et al. found that of the 16 
sleep subgroups assessed, the odds of incident depression at 7.5 year follow-up were highest 17 
among those with insomnia and short sleep duration, and that this association was 18 
independent of psychological coping resources.9 Potential biological underpinnings of 19 
insomnia with short sleep duration have also been explored, and this insomnia phenotype has 20 
been found to be associated with multiple markers of hyperarousal and cardiometabolic 21 
risk.11 This has led some to describe insomnia with objective short sleep duration as the most 22 
“biologically severe” form of insomnia.11 23 
It seems clear that insomnia, short sleep duration, and in particular their combination, predict 24 
prevalence and/or onset of mental health symptoms and associated biomarkers. However, the 25 
 4 
factors which precipitate an illness are not necessarily the same as those which maintain it,12-1 
13 and the extent to which these dimensions of sleep disturbance are associated with mental 2 
health symptom trajectory after onset is currently unclear. Clarifying this association would 3 
have particular clinical utility as sleep disturbance is common among those with mental 4 
disorders yet remains undertreated.14 5 
To date, investigation of the impact of insomnia and/or short sleep duration on mental health 6 
symptom trajectory has been limited by a) considering only a single dimension of sleep 7 
disturbance at a time, b) potential confounders, and c) issues of measurement.15-19 8 
A number of studies have found a prospective link between insomnia and chronicity of 9 
mental health symptoms.15-17 However, these have not considered sleep duration, and not 10 
controlled for important potential confounders such as past mental illness, physical activity, 11 
low social support, stressful life events, or obesity. 12 
Another study by Glozier et al. found that short sleep duration was associated with persistent 13 
psychological distress in young adults 12-18 months after baseline.18 While this study 14 
controlled for multiple important confounders, only one dimension of sleep disturbance was 15 
considered.  16 
Finally, one study has considered multiple dimensions of sleep disturbance and trajectories of 17 
mental health symptoms, while also controlling for important confounders, but this study also 18 
has limitations.19 Van Mill et al. found that both short and long sleep duration, but not 19 
insomnia, were associated with a chronic course of depression and anxiety, and found no 20 
interaction between sleep duration and insomnia.19 They conclude that short and long sleep 21 
duration – but not insomnia – predict a chronic course of mental illness, independent of 22 
disorder symptom severity, and recommend routine assessment of sleep duration to identify 23 
subjects at risk of a chronic course. However, the measure and cut-point used to define 24 
insomnia were validated in a specific sample (postmenopausal women, mean 67.71 years of 25 
 5 
age), and the cut-point used yielded limited sensitivity (53%) and specificity (67%).20 1 
Therefore, a significant proportion of the sample may have been misclassified with regard to 2 
insomnia status, making it difficult to interpret the observed lack of associations with 3 
insomnia.  4 
The limitations described mean the extent to which insomnia, sleep duration, and their 5 
combination predict a chronic trajectory of mental ill-health is currently unclear. If both 6 
dimensions of sleep disturbance predict a chronic trajectory, this would suggest that it may be 7 
necessary to identify and specifically target each, where they are occurring, in order to 8 
maximise the odds of a positive long-term outcome. 9 
1.1 Aims of the Study 10 
The current study aimed to test three primary hypotheses: 11 
1. Insomnia and suboptimal sleep duration (short and/or long duration) will have a 12 
prospective association with chronicity of mental health symptoms.  13 
2. The combination of insomnia symptoms and short sleep duration will be more 14 
strongly associated with chronicity of mental health symptoms than either dimension 15 
of sleep disturbance in isolation. 16 
3. These associations will be robust to adjustment for potential sociodemographic, 17 
physical health, and mental health confounders. 18 
 19 
2. Methods 20 
2.1 Data 21 
Data were obtained through the ongoing Household, Income and Labour Dynamics in 22 
Australia (HILDA) panel survey.21 The survey was approved by the Human Research Ethics 23 
Committee of the University of Melbourne. Commencing in 2001, this survey annually 24 
collects information related to labour market dynamics, family life, and personal well-being. 25 
 6 
It employed a multi-stage sampling approach to obtain a nationally representative sample of 1 
households. Selected households were sent information via mail, and later invited to 2 
participate directly by interviewers. At wave 1 (2001-02), 19,914 individuals participated (a 3 
response rate of 66%). In 2011-12 a further 5,451 persons were added to the cohort (a 4 
response rate of 69%).  5 
Figure 1 summarises the selection of participants into the study. Baseline data for this study 6 
were collected in 2013-14 (wave 13), the first wave in which sleep was assessed. 17,501 7 
individuals participated at this time point. Follow up data were obtained after one year (2014-8 
15; wave 14) and after two years (2015-16; wave 15). Of those who participated in the survey 9 
at baseline, 15,394 (88.0%) also participated in the survey at both follow-up timepoints. Of 10 
these, 12,525 participants (81.4%) had available mental health data at each timepoint. 2,598 11 
(20.7%) of those with full mental health data met criteria for elevated mental health 12 
symptoms (described in section 2.2) at baseline and were included in the study.  13 
Although adolescents experience distinct changes in sleep timing and duration,22 they were 14 
retained in the sample as sleep disturbance has been associated prospectively with mental 15 
illness among this age group.23  16 
Interviews were generally conducted at participant household addresses, with <10% 17 
conducted via phone. The HILDA survey consists of two sections. Each member of a 18 
participating household over the age of 15 was invited to complete the first section with an 19 
interviewer, and the second section alone (without interviewer administration). The second 20 
section, referred to as the ‘self-completion questionnaire’ was comprised of attitudinal and 21 
other questions which respondents may be more comfortable answering privately. After this 22 
section was completed, it was either left with the interviewer, collected at a later date, or 23 
returned by mail. The average time between completion of the self-completion questionnaire 24 
at baseline and one-year follow-up was 11.84 months (SD 1.14; 4.8% missing ≥ one date). 25 
 7 
The average time in between completion of the self-completion questionnaire at one-year and 1 
two-year follow up was 11.91 months (SD 1.03; 4.7% missing ≥ one date). 2 
2.2 Mental illness 3 
Mental illness outcome. The five-item Mental Health Inventory (MHI-5) is a short 4 
questionnaire that can be used to detect patients with anxiety and depression in primary 5 
care.24 The measure demonstrates good internal consistency reliability (Cronbach’s α = 6 
0.84).25 Cuijpers et al.26 reported that a cut-point of 62 yielded acceptable ability to detect 7 
DSM-III-R depression and dysthymia (sensitivity 74%, specificity 91%) and anxiety 8 
disorders (GAD, panic, OCD; sensitivities 62-75%, specificities 89-90%). Participants were 9 
classified as experiencing elevated mental health symptoms (signifying a probable mental 10 
illness) at each timepoint for which their MHI-5 score was less-than-or-equal-to 62. Finally, a 11 
three-level outcome variable mental health symptom trajectory was created based on 12 
participants’ mental health symptoms at one-year and two-year follow up. Not meeting the 13 
MHI-5 criteria at either follow-up time point was classed as recovery. Meeting the MHI-5 14 
criteria at only one of the follow up time points was classed as intermittent mental health 15 
symptoms. Meeting the MHI-5 criteria at both follow-up time points was classed as chronic 16 
mental health symptoms.   17 
2.3 Insomnia symptoms and sleep duration 18 
Insomnia symptoms. Key DSM-V and ICD-10 criteria for insomnia include complaints of 19 
difficulty initiating or maintaining sleep at least 3 times per week27-28. Participants indicated 20 
how frequently over the past month they a) had trouble sleeping because they cannot get to 21 
sleep within 30 minutes, and b) had trouble sleeping because they wake up in the middle of 22 
the night or early morning. Potential responses included ‘not during the past month’, ‘less 23 
than once a week’, ‘once or twice a week’, ‘three or four times a week’, and ‘five or more 24 
times a week’. Experiencing either difficulty at least 3 nights per week was categorized as 25 
 8 
difficulty initiating or maintaining sleep. The fact that many individuals may experience 1 
difficulty initiating or maintaining sleep but have no complaint27-28 was also taken into 2 
account by incorporating subjective sleep quality into the operationalization of insomnia 3 
symptoms. Participants rated their overall sleep quality during the past month as “very good”, 4 
“fairly good”, “fairly bad”, or “very bad”. Responses of “fairly bad” or “very bad” were 5 
classified as poor subjective sleep quality. Finally, a dichotomous composite variable, 6 
insomnia symptoms, was created, with insomnia defined as reporting both difficulty initiating 7 
or maintaining sleep and poor subjective sleep quality. 8 
Sleep duration. Employed participants were asked how many hours of sleep they usually 9 
obtain on work nights and non-work nights. Participants who were not in paid employment at 10 
baseline were asked how many hours of sleep they usually obtain on weekday and weekend 11 
nights. All participants were also asked whether they typically nap either during the daytime 12 
or in the evening, and if so, for how long. For the employed, hours of sleep per week was 13 
then calculated by adding a) the product of workday sleep hours and number of days worked 14 
in primary job, b) the product of non-workday sleep hours and number of days not worked in 15 
primary job, and c) weekly nap duration. For the unemployed, hours of sleep per week was 16 
calculated based on usual weekday and weekend sleep hours weighted according to number 17 
of weekday (5) and weekend (2) nights, and weekly nap duration. Average sleep duration was 18 
calculated by dividing hours of sleep per week by seven. As the relationship between sleep 19 
duration and mental health is non-linear, with both short and long sleep duration being 20 
associated with worse outcomes,29 sleep duration was then converted to a four-category 21 
variable (< 6 h, ≥ 6 to < 7 h, ≥ 7 to < 8 h, ≥ 8 h). These cut-offs were selected as typically 22 
sleep duration of < 6 h is categorized as short,5,10,19 the range for normal sleep duration varies 23 
between 6-8 hours,5,10 and splitting within this range allows for possible differences in 24 
 9 
strength of associations. For analyses ≥ 7 to < 8 h sleep duration was set as the reference 1 
group, as this group had the lowest prevalence of chronic mental health symptoms.  2 
2.4 Potential covariates 3 
The current study accounted for a range of factors that are associated with sleep disturbance 4 
and/or mental health symptoms. All potential covariates are from baseline unless otherwise 5 
stated. Variable definitions/categorizations were based on previous research,30 and greater 6 
detail is provided in Appendix, Table A.1.  7 
 8 
Demographics and socioeconomic status. Education was classified as high (masters or 9 
doctorate, graduate diploma, graduate certificate, bachelor or honours), intermediate 10 
(advanced diploma, diploma, Certificate III or IV, completed high school), and low (not 11 
completed high school). Dichotomous variables indicated whether respondents were 12 
partnered (married or in a de facto relationship), employed, of Aboriginal or Torres Strait 13 
Islander background (assumed no if not confirmed), or spoke English as a second language 14 
(assumed no if not confirmed). Equivalised household income was calculated according to 15 
the ‘modified Organization for Economic Cooperation and Development (OECD) scale’,31 16 
with lower limits set to 0 (i.e. negative values were not permitted). Extreme scores at the 17 
upper-end of the distribution were top-coded, with upper limits set to the seventy-fifth 18 
percentile plus 1.5 times the interquartile range. Low social support was assessed with a 10-19 
item measure described in Milner et al.32 Items require respondents to report level of 20 
agreement with statements such as “I have no one to lean on in times of trouble” on an 8-21 
point Likert scale. The measure demonstrates good internal consistency reliability 22 
(Cronbach’s α = 0.84).31 Low social support was defined as average scores below 4.69, as 23 
such scores have been found to be associated with poorer mental health.31 Stressful life 24 
events were based on endorsing the occurrence of at least one of a number of stressful life 25 
 10 
events (e.g. death of a family member, loss of relationship, loss of employment) in the two 1 
years prior to T3 (reported at T2 & T3).33 2 
Physical health and related behaviours: Binary variables reflected physical health 3 
characteristics and behaviours as follows: Pain based on ratings of ‘severe’ or ‘very severe’ 4 
on a 6-point scale,34 drinking behaviour based on drinking alcohol 5 days per week or more,35 5 
smoking behaviour based on smoking daily,36  obesity based on a BMI of 30 or higher,37 6 
chronic illness based on self-reported diagnoses of type I or II diabetes, heart disease or 7 
circulatory disease, hypertension, asthma, cancer, arthritis or osteoporosis, or other serious 8 
illness, with the exception of mental health diagnoses38; potential undiagnosed sleep apnea 9 
based on self-reported trouble sleeping due to coughing or snoring at least 3 nights per 10 
week,39 and physical activity based on moderate-to-vigorous physical activity more than 3 11 
times per week.40  12 
Mental illness and treatment: The presence of a previous episode of mental illness (of which 13 
the insomnia symptoms could be a residual symptom) was defined as meeting the above 14 
MHI-5 criteria at any of waves 1-12 after initially joining the study (i.e. up to twelve years 15 
previously). Self-reported sleep and other psychiatric medication use was also obtained, and 16 
the MHI-5 was included as a continuous measure of mental health. 17 
2.5 Statistical analyses 18 
All analyses were conducted using SPSS version 25 (IBM). Descriptive statistics were 19 
obtained for the final sample, with differences between groups defined by mental health 20 
symptom trajectory assessed via t-tests and chi-squared tests. Univariate associations between 21 
mental health symptom trajectory and each of the predictors and covariates, and associations 22 
between sleep variables (insomnia symptoms and sleep duration) and covariates were 23 
assessed via logistic regression.  24 
 11 
Associations between sleep variables and mental health symptom trajectory were then 1 
adjusted for covariates that were found to be associated with both the outcome measure and 2 
at least one of the sleep variables. For adjusted models, multiple imputation was used to 3 
impute missing values41 with the Markov chain Monte Carlo method, under the assumption 4 
that data were missing at random (MAR), using all independent variables and two-way 5 
interaction terms as predictors. Estimates from 30 imputed samples were pooled for 6 
analysis.42 7 
The analysis was hierarchical, with mental health symptom trajectory first regressed on 8 
baseline insomnia symptoms or sleep duration (in separate analyses), adjusting for age and 9 
sex. In subsequent steps, other covariates were added to the model in blocks ordered from 10 
those expected to have a lesser attenuating effect on the coefficient for sleep variables, to 11 
those expected to have the greatest attenuating effect or found to be most strongly associated 12 
with mental illness outcome. After the first step, other sociodemographic covariates were 13 
added to the model, followed by physical health covariates, then mental health covariates. For 14 
each model, linearity of the relationships between logits and predictors was assessed using 15 
the Box-Tidwell procedure. For continuous covariates which were nonlinear with the logit, 16 
two polynomial terms were created by respectively squaring and cubing the continuous 17 
variable.43 These polynomial terms were entered with the associated continuous variable (e.g. 18 
age-squared and age-cubed entered with age). Quadratic terms were included at each step of 19 
the model at which either it or the cubic term was significant, while a cubic term was only 20 
included if it was significant. 21 
In another model both sleep variables were added to fully-adjusted models to determine 22 
whether each had an independent effect on mental health symptom trajectory.  23 
In a separate model, interactions between insomnia symptoms and sleep duration, adjusted 24 
for covariates, were assessed. Interactions between insomnia symptoms and each of the 25 
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covariates were also included in this model to take into account potential variation in 1 
coefficient slopes based on factors other than the potential moderator of interest, and the 2 
sample was large enough for inclusion of these additional terms to be feasible. Interactions 3 
between sleep variables and age group (<25 years, 25-44 years, 45-64 years, 65+ years),30 4 
sex, and past mental health were also assessed in this manner.  5 
The treatment of multiple-level categorical variables in regression analyses would not allow 6 
all possible categories to be compared. Therefore, as in previous studies,10 we also created a 7 
categorical variable with 6 groups defined by combinations of insomnia symptoms and sleep 8 
duration (categories in Table 4). For this analysis, sleep duration of < 6 h or ≥ 6 to < 7 h were 9 
defined as “short sleep duration”. The initial analysis was then repeated using this “joint sleep 10 
variable”, with the combination of no insomnia symptoms and ≥ 7 to < 8 h sleep duration as 11 
the reference group. 12 
All regressions were re-run with original (non-imputed) data, to assess whether associations 13 
of insomnia symptoms or sleep duration with mental illness outcome were sensitive to data 14 
imputation. Any differences between analyses using imputed and original (non-imputed) data 15 
are reported in the results. 16 
 17 
3. Results 18 
For those who had baseline mental health data, missing mental health data at one or two-year 19 
follow-up was negatively associated with elevated mental health symptoms at baseline, but 20 
not with insomnia symptoms or sleep duration. Missing data comprised 0-4.8% of values per 21 
variable, with the exception of psychiatric medication (8.1% missing), past mental illness 22 
(9.1%), and chronic illness (15.7%). See Appendix Table A.2 for missing data proportions 23 
and characteristics of original and imputed data sets.  24 
 25 
 13 
3.1 Descriptive statistics 1 
Participants in the final sample ranged from 15 to 94 years of age (M = 44.35, SD = 17.86). 2 
This included 125 individuals <18 years of age. At two-year follow-up, a total of 673 3 
participants (25.9% of the sample) were assessed as meeting criteria for recovery, 711 4 
(27.4%) as experiencing intermittent mental health symptoms, and 1,214 (46.7%) as 5 
experiencing chronic mental health symptoms. A total of 1,056 (40.6%) participants were 6 
assessed as experiencing insomnia symptoms at baseline. Characteristics of the sample are 7 
found in Table 1, stratified by mental health symptom trajectory. See Table 2 for associations 8 
between insomnia symptoms and sleep duration.  9 
In univariate logistic regression analyses the majority of independent variables (n = 19/23) 10 
were associated with mental health symptom trajectory. All covariates associated with mental 11 
health symptom trajectory were also associated with insomnia symptoms and/or sleep 12 
duration. See Appendix Tables A.3-A.5 for associations of mental health symptom trajectory 13 
and sleep variables with other predictors/covariates.  14 
3.2 Insomnia symptoms 15 
Associations of sleep variables with mental health symptom trajectory are outlined in Table 16 
3. Adjusted for age and sex, insomnia symptoms were associated with intermittent mental 17 
health symptoms (odds ratio (OR) 1.43, 95% CI 1.15 – 1.80) and chronic mental health 18 
symptoms (OR 2.16, 95% CI 1.77 – 2.65). After adjustment for physical health covariates 19 
insomnia symptoms were no longer associated with intermittent mental health symptoms (OR 20 
1.23, 95% CI 0.97 – 1.56). After mental health covariates were accounted for, insomnia 21 
symptoms were still associated with chronic mental health symptoms (OR 1.40, 95% CI 1.11 22 
– 1.76). When further adjusted for sleep duration, insomnia symptoms remained a significant 23 
predictor of chronic mental health symptom (OR 1.34, 95% CI 1.05 – 1.72). 24 
 14 
As those with “no insomnia symptoms” included those with difficulties initiating and 1 
maintaining sleep (DIMS) but normal sleep quality, we considered the possibility that this 2 
subgroup may differ from the remainder of the “no insomnia symptoms” group i.e. those with 3 
no DIMS and normal sleep quality. However, post-hoc analyses indicated that difficulties 4 
initiating or maintaining sleep in the absence of poor sleep quality was not associated with 5 
greater adjusted odds of intermittent (OR 1.03, 95%CI 0.68 – 1.57) or chronic (OR 1.28, 95% 6 
CI 0.86 – 1.91) mental health symptom trajectories, compared to those with no DIMS and 7 
normal sleep quality. 8 
3.3 Sleep duration 9 
Sleep duration was associated with chronic mental health symptoms after adjustment for 10 
sociodemographics, physical health, and mental health. Sleeping < 6h (OR 1.48, 95% CI 1.11 11 
– 1.98), ≥ 6 to < 7 h (OR 1.65, 95% CI 1.23 – 2.22) and >8 h (OR 1.34, 95% CI 0.99 – 1.81) 12 
per night were associated with greater likelihood of chronic mental health symptoms at 2-13 
year follow-up compared to sleeping ≥ 7 to < 8 h per night, though statistical significance 14 
was not reached for > 8 h.  15 
After adjustment for insomnia symptoms, the trend remained for sleep duration to be 16 
association with chronic mental health symptoms. Sleeping < 6 h (OR 1.32 95% CI 0.97 – 17 
1.80, p = .077), ≥ 6 to < 7 h (OR 1.59, 95% CI 1.18 – 2.14, p = .002), and ≥ 8 h per night (OR 18 
1.36, 95% CI 1.00 – 1.84, p = .047) continued to be associated with chronic mental health 19 
symptoms. The pattern was similar using non-imputed data, though sleeping < 6 h (OR 1.50, 20 
95% CI 1.04 – 2.16) but not ≥ 8 h (OR 1.42, 95% CI 0.98 – 2.05, p = .064) reached statistical 21 
significance. 22 
In a sensitivity analysis, when < 6 h sleep duration was further broken down into ≤ 5 h (n = 23 
367 in original data) and > 5 to < 6 h (n = 362 in original data), sleeping ≤ 5 h (OR 1.90, 95% 24 
 15 
CI 1.29 – 2.79) but not > 5 to < 6 h (OR 1.25, 95% CI 0.89 – 1.75) was associated with 1 
chronic mental health symptoms after full covariate adjustment.  2 
 3 
3.4 Interactions 4 
There was no significant interaction between insomnia symptoms and sleep duration. 5 
However, the analysis using the ‘joint sleep variable’ defined by combinations of insomnia 6 
symptoms and sleep duration suggested that insomnia symptoms had a greater independent 7 
association with chronic mental health symptoms when combined with < 7 h per night sleep 8 
duration (Table 4).  9 
There were no significant interactions between sleep variables and sex.  10 
There was no significant interaction between age group and insomnia symptoms. There was a 11 
significant interaction between age group and sleep duration. Sleeping < 6 h per night was 12 
more strongly associated with chronic mental health symptoms for those aged 45-64 years 13 
than those aged < 25 years (OR 2.51, 95% CI 1.04 – 6.09, p = .041). There was also a trend 14 
for sleeping < 6 h per night to be more associated with chronic mental health symptoms for 15 
those aged 25-44 years than those aged < 25 years (OR 2.32, 95% CI 0.93 – 5.80, p = .072), 16 
which was significant using non-imputed data.  17 
There was also a significant interaction between insomnia symptoms and past mental illness 18 
(OR 2.49, 95% CI 1.17 – 5.33, p = .019). For those with past mental illness, insomnia 19 
symptoms, fully-adjusted, were associated with greater risk of chronic mental health 20 
symptoms at two-year follow-up (OR 1.56, 95% CI 1.21 – 2.01), while for those without past 21 
mental illness insomnia symptoms were not associated with increased risk of chronic mental 22 
health symptoms (OR 0.73 95% CI 0.32 – 1.68). This interaction was not significant using 23 
non-imputed data (OR 2.26, 95% CI 0.98 – 5.22, p = .055), but the pattern of a significant 24 
association for those with a prior history of mental illness and lack of association for those 25 
 16 
without such a history remained. There was no interaction between sleep duration and past 1 
mental illness. 2 
4. Discussion  3 
To our knowledge, this is the first study to show that both insomnia and sleep duration, alone 4 
and in combination, are associated with the trajectory of elevated mental health symptoms 5 
after adjustment for a wide range of potential confounders, in a sample aged across the adult 6 
lifespan. Insomnia symptoms were more predictive of a chronic trajectory for those with a 7 
history of probable mental illness. The combination of insomnia symptoms with short sleep 8 
duration (< 7 h per night) was more predictive of chronic mental health symptoms than either 9 
dimension of sleep disturbance alone.  10 
The findings related to insomnia symptoms were partly consistent with most previous 11 
research. They are in line with the results of previous studies which suggest an association 12 
between insomnia and mental illness chronicity.15-17 The current results build on these 13 
findings by adjusting for a range of potential confounders not previously considered.   14 
There is also a lack of previous research assessing potential interaction between sleep 15 
disturbance and mental health history. We observed that insomnia symptoms were more 16 
predictive of chronic mental health symptoms for those with a history of likely mental illness. 17 
It is possible that those with a history of mental illness are more likely to be experiencing 18 
chronic (rather than acute) insomnia, and that this stable insomnia is associated with worse 19 
mental health prognosis. However, the hypothesis was untestable here as no measure of 20 
insomnia symptom chronicity was available, and the possibility warrants future exploration.  21 
Our findings related to sleep duration are also consistent with previous research. Large-scale 22 
studies have found that after adjustment for potentially confounding variables, shorter sleep 23 
duration was associated with increased risk of persistently elevated psychological distress 12-24 
18 months later,18 and 2-year chronic course trajectory of depression/anxiety.19  We also 25 
 17 
found that short and long sleep duration were associated with a chronic course trajectory of 1 
mental health symptoms, after adjusting for a wider range of covariates than in previous 2 
research (though long sleep duration did not reach statistical significance). 3 
Perhaps the primary finding of the current study was that the combination of insomnia 4 
symptoms and short sleep duration were more predictive of a chronic course of mental health 5 
symptoms than either insomnia or short sleep duration alone. This extends the findings of 6 
previous studies.7,9 Furihata et al.7 observed an “additive” effect of sleep disturbance 7 
dimensions on depression incidence in a population of older women (mean age 80.1 years).7 8 
Fernandez-Mendoza et al.9 found that insomnia with short sleep duration is associated with 9 
incident depression independent of coping resources and other covariates. The current study 10 
demonstrates a similar “combined” effect of insomnia symptoms and short sleep duration, but 11 
in this case shows that a) this effect is also associated with trajectory (as opposed to 12 
incidence) of mental health symptoms, b) this effect is robust to adjustment for a wider range 13 
of confounders than those included previous studies.  14 
It should be noted that one previous study adjusting for a range of confounders suggested that 15 
insomnia does not contribute to the impact of sleep disturbance on chronicity of common 16 
mental disorders.19 However, this may be explained by differences in measurement. Rather 17 
than using diagnostic criteria, insomnia in this earlier study was determined using a measure 18 
which has previously been found to have limited sensitivity (53%) and specificity (67%) 19 
when used to detect insomnia, and was validated in an age-and-sex-restricted sample of 20 
postmenopausal women.20 Resultant misclassification may have prevented the identification 21 
of a relationship between insomnia and illness chronicity. Furthermore, the finding in the 22 
current study that the combination of insomnia and short sleep duration is more strongly 23 
associated with mental health chronicity than either sleep dimension in isolation is supported 24 
by growing evidence that insomnia with objective short sleep duration is the most 25 
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“biologically severe” form of the disease, as evidenced by associations with multiple 1 
physiological markers of hyperarousal.11  2 
It is important to consider that in theory, the sleep disturbance which is associated with 3 
chronicity of mental ill-health may simply be a residual symptom of prior mental illness, or 4 
indicative of more severe mental health symptoms at baseline, rather than a 5 
causal/maintaining factor. However, these factors (past mental health and baseline mental 6 
health symptoms) were controlled for in the current analyses. Furthermore, it is also possible 7 
that the attenuation of effects following covariate adjustment to some degree represents over 8 
adjustment.44 For example, controlling for an intermediate variable on a causal path from 9 
sleep disturbance to mental health symptom chronicity (e.g. continuous mental health at 10 
baseline, possibly a function of sleep disturbance) may bias the effect of sleep disturbance 11 
towards the null.  12 
Therefore, the significant association of insomnia symptoms and sleep duration with mental 13 
health symptom trajectory, even after adjustment for multiple confounders, suggests that 14 
maximising the probability of mental illness recovery may require targeting sleep disturbance 15 
when present, regardless of other illness-maintaining factors, notably including the baseline 16 
severity of mental health symptoms and past mental illness. It is also noteworthy that 17 
associations of sleep disturbance with mental health symptom chronicity appeared strongest 18 
for those with insomnia symptoms and short sleep duration combined as opposed to either in 19 
isolation. Combined with evidence that insomnia with objective short sleep duration is more 20 
biologically severe than insomnia with normal sleep duration,11 this suggests intervention is 21 





4.1 Limitations & Future Work 1 
The strength of the above recommendations is tempered by several limitations in the present 2 
study. It is possible that had complete diagnostic criteria been used to classify probable 3 
mental illness (rather than a cut-point on a mental health scale), sleep disturbance may have 4 
been more or less strongly associated with chronicity. The measure we used shows good 5 
ability to discriminate between cases and non-cases of depression and anxiety,26 and excellent 6 
specificity in particular means nearly the whole sample might be expected to meet criteria for 7 
depression and/or anxiety. However, using diagnostic criteria would also make it possible to 8 
determine whether sleep disturbance is predictive of illness chronicity for particular 9 
diagnoses. The temporal “coverage” of the measures was also a limitation, as illness during 10 
the 1-year period between each timepoint was not assessed. This means the true trajectory of 11 
illness was not assessable. However, those who were ill at both follow-up timepoints might 12 
be expected to be doing worse on average than those who were not, and so the measure is 13 
likely at least a good proxy for chronicity. There were also limitations in the measurement of 14 
covariates. For example, the measure of alcohol consumption accounted for frequency but not 15 
quantity of consumption, and the measure of unemployment did not distinguish between 16 
unemployment due to retirement versus inability to find work. 17 
Another limitation is the reliance on self-report and potential associated inaccuracies. This is 18 
especially relevant for our population, as those with mental illness are often not individually 19 
accurate in estimating their habitual sleep duration.45 Further assessment of the relationship 20 
between sleep disturbance and mental health symptom trajectories using objective measures 21 
of sleep (and adjusting for potential confounders) is therefore warranted.  22 
Finally, the results of the current study suggest that it may be especially important to address 23 
insomnia when combined with short sleep duration, but do not indicate how. It is beyond the 24 
scope of this paper to thoroughly explore this question. However, one notable hypothesis is 25 
 20 
that patients with insomnia and short sleep duration, who display higher physiological arousal 1 
and poorer response to cognitive-behavioural interventions for insomnia (CBT-I), may 2 
benefit from pharmacotherapy or combined therapy (CBT-I + medication).46 In any case, the 3 
current results indicate that research confirming effective interventions for sleep disturbance 4 
and its phenotypes in psychiatric populations may aid in optimising mental health symptom 5 
trajectories.  6 
4.2 Conclusion 7 
Notwithstanding acknowledged limitations, the results of the current study suggest that 8 
insomnia and short sleep duration are not simply symptoms of physical or mental illness, but 9 
predict a chronic trajectory of elevated mental health symptoms. This speaks to a need for 10 
those with mental health symptoms and their clinicians to identify and address sleep 11 
disturbance (i.e. insomnia and/or short sleep duration) when present, regardless of other 12 
illness-maintaining factors. This may be particularly important for those presenting with the 13 
combination of insomnia and short sleep duration. 14 
 15 
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Table 1. Characteristics of the sample as a whole and stratified by mental health symptom trajectory. 
 Whole sample 
(n = 2,598)† 
 Recovery  
(n = 673) 
Intermittent 
(n = 711) 
Chronic 
(n = 1,214) 
  
 Mean (SD)  Mean (SD) Mean (SD) Mean (SD) F p 
Age 44.35 (17.86)  42.7 (17.5) 42.5 (18.0) 46.4 (17.8) 14.63 <.001 
        
Household income ($10k’s) 9.62 (6.68)  10.72 (6.96) 9.71 (6.52) 8.96 (6.55) 15.31 <.001 
        
Mental health (MHI-5 
continuous) 
48.03 (11.99)  52.6 (8.8) 49.6 (10.8) 44.6 (13.1) 113.15 <.001 
        
 n (%)  n (%) n (%) n (%) χ2 p 
Insomnia symptoms 1056 (40.6)  202 (30.3) 270 (38.6) 584 (48.9) 63.39 <.001 
        
Sleep duration        
< 6 h  729 (28.3)  152 (22.7) 192 (27.3) 385 (32.0) 44.80 <.001 
≥ 6 to < 7 h 574 (22.3)  146 (21.8) 137 (19.5) 291 (24.2)   
≥ 7 to < 8 h 708 (27.5)  228 (34.0) 216 (30.7) 264 (21.9)   
≥ 8  567 (22.0)  144 (21.5) 159 (22.6) 264 (21.9)   
        
Sex (female) 1506 (58.0)  381 (56.6) 438 (61.6) 687 (56.6) 5.31 .070 
        
Education (low) 881 (33.9)  200 (29.7) 258 (36.3) 423 (34.8) 9.17 .057 
Education (intermediate) 1193 (45.9)  319 (47.4) 314 (44.2) 560 (46.1)   
Education (high) 524 (20.2)  154 (22.9) 139 (19.5) 231 (19.0)   
        
Partnered 1470 (56.6)  404 (60.0) 400 (56.3) 666 (54.9) 4.75 .093 
Unemployed 1221 (47.0)  244 (36.3) 323 (45.4) 654 (53.9) 54.91 <.001 
ATSI background 84 (3.2)  15 (2.2) 22 (3.1) 47 (3.9) 3.79 .150 
English 2nd language 305 (11.7)  66 (9.8) 81 (11.4) 158 (13.0) 4.41 .110 
Low social support 1350 (53.2)  243 (37.0) 359 (51.8) 748 (63.1) 116.32 <.001 
Stressful life events  2103 (81.5)  542 (81.1) 590 (83.3) 971 (80.6) 2.31 .315 
Pain 418 (16.1)  68 (10.1) 106 (14.9) 244 (20.1) 32.95 <.001 
Drinking >4 times/week 322 (12.5)  86 (12.9) 81 (11.5) 155 (12.9) 0.90 .638 
Smoking daily 522 (20.2)  107 (16.0) 143 (20.3) 272 (22.5) 11.32 .003 
Obesity 718 (29.0)  154 (23.8) 208 (30.8) 356 (31.0) 11.89 .003 
Chronic illness 1190 (54.3)  267 (45.1) 300 (50.1) 623 (62.4) 50.65 <.001 
Potential sleep apnea 266 (10.4)  40 (6.0) 74 (10.6) 152 (12.7) 20.51 <.001 
Physical Activity > 3 times/week 670 (25.9)  198 (29.5) 199 (28.1) 273 (22.6) 13.11 .001 
Past mental illness 2082 (88.1)  441 (75.6) 554 (87.0) 1087 (95.2) 142.19 <.001 
Sleep medication (1+ per week) 474 (18.5)  43 (6.8) 86 (13.1) 280 (25.4) 107.56 <.001 
Psychiatric medication (regular) 409 (17.1)  72 (10.8) 123 (17.5) 279 (23.3) 44.76 <.001 
† Reported n’s and percentages of those in each mental health symptom trajectory category with listed characteristics are 
based on data pre-imputation. N missing values (%): age = 0 (.0), income = 0 (.0),  mental health (MHI-5 continuous) = 0 
(.0),  insomnia = 38 (1.5), sleep duration = 20 (0.8),  sex = 0 (.0), education = 0 (.0), partnered = 0 (.0), unemployed = 0 
(.0),  ATSI background = 0 (.0), English 2nd language = 0 (.0), low social support = 62 (2.4),  stressful life events = 17 
(.7),  pain = 5 (.2), drinking = 21 (.8), smoking = 18 (.7), obesity = 125 (4.8), chronic illness = 408 (15.7),  potential sleep 
apnea = 36 (1.4), physical activity = 10 (.4), past mental illness = 236 (9.1), sleep medication = 29 (1.1), other psychiatric 
medication = 210 (8.1). 
 
Table 2. Association of insomnia symptoms with sleep duration. 
  No insomnia 
symptoms 
(n = 1,496/2,541)† 
Insomnia 
symptoms 
(n = 1,045/2,541)† 
 
Sleep duration N n (%)‡ n (%)‡ χ2 p 
< 6 h  716 207 (13.8) 509 (48.7) 411.48 <.001 
≥ 6 to < 7 h 566 337 (22.5) 229 (21.9)   
≥ 7 to < 8 h 700 526 (35.2) 174 (16.7)   
≥ 8 h 559 426 (28.5) 133 (12.7)   
† n = 57 missing either sleep duration or insomnia symptoms. 
‡ % of those within insomnia symptoms category who report sleep duration within specified 
range. 
 
Table 3. Adjusted associations of sleep variables with mental health symptom trajectory. 
 
 
Intermittent mental health 
symptoms 
(n = 711/2,598) 
 
Chronic mental health 
symptoms 
(n = 1,214/2,598) 
  AOR (95% CI)† p  AOR (95% CI)† p 
Insomnia symptoms (yes/no)       
      Age and sex adjusted  1.43 (1.15 – 1.80) .002  2.16 (1.77 – 2.65) <.001 
      Sociodemographics adjusted‡  1.34 (1.07 – 1.69) .011  1.96 (1.59 – 2.41) <.001 
      Physical health adjusted§  1.23 (0.97 – 1.56) .081  1.76 (1.42 – 2.18) <.001 
      Mental health adjusted¶  1.11 (0.87 – 1.41) .406  1.40 (1.11 – 1.76) .004 
       
Sleep duration (categories)       
      Age and sex adjusted       
< 6 h   1.33 (1.00 – 1.77) .052  2.06 (1.59 – 2.68) <.001 
≥ 6 to < 7 h  0.98 (0.73 – 1.33) .915  1.70 (1.30 – 2.22) <.001 
≥ 7 to < 8 h  reference   reference  
≥ 8 h  1.15 (0.86 – 1.55) .335  1.57 (1.19 – 2.05) .001 
      Sociodemographics adjusted‡,††       
< 6 h   1.19 (0.89 – 1.59) .250  1.72 (1.31 – 2.26) <.001 
≥ 6 to < 7 h  0.97 (0.72 – 1.32) .859  1.65 (1.26 – 2.18) <.001 
≥ 7 to < 8 h  reference   reference  
≥ 8 h  1.08 (0.80 – 1.46) .602  1.43 (1.08 – 1.90) .013 
      Physical health adjusted§       
< 6 h   1.11 (0.83 – 1.49) .487  1.61 (1.22 – 2.12) <.001 
≥ 6 to < 7 h  0.95 (0.70 – 1.29) .755  1.63 (1.23 – 2.15) <.001 
≥ 7 to < 8 h  reference   reference  
≥ 8 h  1.04 (0.77 – 1.41) .777  1.36 (1.02 – 1.80) .034 
      Mental health adjusted¶       
< 6 h   1.06 (0.79 – 1.43) .689  1.48 (1.11 – 1.98) .008 
≥ 6 to < 7 h  0.96 (0.70 – 1.31) .790  1.65 (1.23 – 2.22) <.001 
≥ 7 to < 8 h  reference   reference  
≥ 8 h  1.03 (0.76 – 1.40) .835  1.34 (0.99 – 1.81) .056 
† Based on multinomial logistic regressions, with recovery (n = 673/2,598) as reference group. 
‡ Adjusted for covariates from previous stages plus income, education, partnered, unemployment, English 
as 2nd language, low social support 
§ Adjusted for covariates from previous stages plus pain, physical activity, smoking, potential sleep apnea, 
obesity, chronic illness 
¶ Adjusted for covariates from previous stages plus mental health continuous (MHI-5), past mental illness, 
sleep medication, psychiatric medication 
†† Quadratic and cubic terms included for age 




Intermittent mental health 
symptoms 
(n = 711/2,598) 
 
Chronic mental health 
symptoms 
(n = 1,214/2,598) 
 n† AOR (95% CI)‡ p  AOR (95% CI)‡ p 
 Age and sex adjusted       
No insomnia symptoms, < 7 h 544 1.01 (0.74 – 1.38) .946  1.44 (1.08 – 1.92)  .012 
Insomnia symptoms, < 7 h 738 1.61 (1.18 – 2.20) .003  3.15 (2.37 – 4.18) <.001 
No insomnia symptoms, ≥ 7 to < 8 h 526 reference   reference  
Insomnia symptoms, ≥ 7 to < 8 h 174 1.53 (0.97 – 2.40) .067  1.81 (1.18 – 2.78) .006 
No insomnia symptoms, ≥ 8 h 426 1.29 (0.92 – 1.79) .136  1.63 (1.19 – 2.22) .002 
Insomnia symptoms, ≥ 8 h 133 1.26 (0.73 – 2.20) .409  2.70 (1.67 – 4.37) <.001 
 Adjusted for all covariates§       
No insomnia symptoms, < 7 h  0.91 (0.62 – 1.33) .613  1.34 (0.92 – 1.94) .126 
Insomnia symptoms, < 7 h  1.28 (0.86 – 1.91) .217  2.35 (1.60 – 3.45) <.001 
No insomnia symptoms, ≥ 7 to < 8 h  reference   reference  
Insomnia symptoms, ≥ 7 to < 8 h  0.98 (0.56 – 1.72) .956  1.04 (0.60 – 1.81) .882 
No insomnia symptoms, ≥ 8 h  1.15 (0.75 – 1.75) .518  1.46 (0.96 – 2.22) .077 
Insomnia symptoms, ≥ 8 h  0.84 (0.41 – 1.72) .640  1.31 (0.67 – 2.56) .431 
† n’s based on original data. 
‡ Effect sizes based on multinomial logistic regressions using pooled imputed data, with recovery (n = 673/2,598) as 
reference group. 
§ Adjusted for covariates from the previous stage plus income, education, partnered, unemployment, English as 2nd 
language, low social support, pain, physical activity, smoking, potential sleep apnea, obesity, chronic illness, mental 
health continuous (MHI-5), past mental illness, sleep medication, psychiatric medication. 
 
 
